These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27437776)

  • 1. YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid.
    Xu G; Wang J; Wu F; Wang N; Zhou W; Wang Q; Pan W; Ao G; Yang J
    Oncotarget; 2016 Aug; 7(32):52150-52165. PubMed ID: 27437776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth.
    Wang L; Wang J; Cao Y; Li W; Wang Y; Xu J; Xu G
    Eur J Pharmacol; 2019 Jan; 842():281-290. PubMed ID: 30391347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells.
    Li Y; Xu Q; Yang W; Wu T; Lu X
    Gene; 2019 Sep; 712():143956. PubMed ID: 31271843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
    Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J
    Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
    Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J
    J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-hepatocellular carcinoma activity of novel O
    Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
    Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [YAP regulates the proliferation and modifies the sensitivity to sorafenib in hepatocellular carcinoma cells].
    Guo LW; Shao GL; Luo J; Hao WY; Yao Z; Zheng JP
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):818-823. PubMed ID: 30481931
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
    Gao C; Li X; Yu S; Liang L
    J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
    Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells.
    Liese J; Abhari BA; Fulda S
    Cancer Lett; 2015 Aug; 365(1):47-56. PubMed ID: 25917078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP activation is an early event and a potential therapeutic target in liver cancer development.
    Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A
    J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
    Liese J; Hinrichs TM; Lange M; Fulda S
    Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP.
    Shyu MH; Kao TC; Yen GC
    J Agric Food Chem; 2010 May; 58(10):6110-8. PubMed ID: 20415421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro.
    Wang Y; Luo Y; Li C; Zhang X; Pi C; Yu L; Wang S; Zhong Z
    Drug Des Devel Ther; 2017; 11():955-968. PubMed ID: 28392677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
    Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
    Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.
    Lee ZW; Zhou J; Chen CS; Zhao Y; Tan CH; Li L; Moore PK; Deng LW
    PLoS One; 2011; 6(6):e21077. PubMed ID: 21701688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.